arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Lyell Immunopharma, Inc.

LYEL

$14.66 ▲ +0.48 (+3.39%) at close

27 Visible periods

26 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Lyell Immunopharma, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $320.7M

Dividend Yield —

Revenue Growth -71.4% ↘

Op. Margin None

ROIC -12.8% ↗

FCF / Share $-1.76

Trailing P/E —

Price / Book 1.3x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

27-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$2.00K

↓ -71.4% —

Net Income Profit after all expenses

$-24.15M

↑ +53.7% —

Operating Margin Operating profit as % of sales

-30.6%

↑ +70.7% —

FCF / Share Free cash flow per share

$-1.76

↑ +52.7% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue Growth YoY (%)	-71.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-993%)	-45.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-668%)	-55.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-799%)	-38.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-581%)	133.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1567%)	-15.4% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-292%)	36.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+350%)	-51.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-748%)	-95.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1292%)	-100.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1350%)	733.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+9067%)	-99.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1349%)	-88.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1203%)	1614.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+20082%)	-99.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1349%)	1260.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+15650%)	-77.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1067%)	22.1% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+176%)	157.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1868%)	-15.7% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-296%)	—	—	—	—	—	—	—
EPS Growth YoY (%)	69.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	46.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	37.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	19.7% Good → Good Stable Year-over-year change in earnings per share Optimal: > 10%	25.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	19.9% Good → Good Stable Year-over-year change in earnings per share Optimal: > 10%	15.0% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	30.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	11.1% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-2895.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	28.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-73.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	3.6% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	83.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-40.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	89.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	91.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	53.7% Excellent ↑ Excellent Improving Year-over-year change in net income	26.7% Excellent ↑ Excellent Improving Year-over-year change in net income	12.9% Fair ↑ Fair Improving Year-over-year change in net income	6.8% Fair ↑ Fair Improving Year-over-year change in net income	14.0% Fair ↑ Fair Improving Year-over-year change in net income	-262.6% Weak ↓ Weak Declining Year-over-year change in net income	12.3% Fair ↑ Fair Improving Year-over-year change in net income	28.3% Excellent ↑ Excellent Improving Year-over-year change in net income	9.4% Fair ↑ Fair Improving Year-over-year change in net income	-530.3% Weak ↓ Weak Declining Year-over-year change in net income	27.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-75.9% Weak ↓ Weak Declining Year-over-year change in net income	1.7% Caution ↓ Caution Declining Year-over-year change in net income	90.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-43.7% Weak ↓ Weak Declining Year-over-year change in net income	42.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-23.8% Weak ↑ Weak Improving Year-over-year change in net income	-115.4% Weak ↓ Weak Declining Year-over-year change in net income	-36.8% Weak Weak Year-over-year change in net income	37.8% Excellent Excellent Year-over-year change in net income	—	—	—	—	—	—	—
FCF Growth YoY (%)	52.7% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-12.7% Weak Weak Year-over-year change in free cash flow	—	—	—	13.6% Fair Fair Year-over-year change in free cash flow	—	—	—	18.9% Good Good Year-over-year change in free cash flow	—	—	—	92.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-68.7% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-95.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	71.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-93.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-76.7% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-84.3% Weak → Weak Stable Compound annual revenue growth over 3 years	-76.9% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-83.0% Weak → Weak Stable Compound annual revenue growth over 3 years	-89.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-82.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-71.4% Weak Weak Compound annual revenue growth over 3 years	-79.5% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	-75.9% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-69.6% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-57.4% Weak Weak Compound annual revenue growth over 5 years	-69.7% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	-30.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-304%)	—	-104.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-795%)	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	-17.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-245%)	—	-101.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-947%)	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	-92.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	1.60x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.23x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.05x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.25x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.69x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.71x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	5.34x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	0.85x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.52x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.33x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	-12.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-40.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-12.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-13.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-41.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.5% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-7.2% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-7.3% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-7.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-1.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	13.1% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	10.7% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	10.9% Good Good Return earned on debt + equity capital invested Optimal: > 10%	33.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-12.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-37.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-41.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-7.9% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-8.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	—	-7.4% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-7.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-6.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-6.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	-8.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-159%)	-56.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-478%)	-11.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-179%)	-14.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-195%)	-15.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-203%)	-50.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-434%)	-8.4% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-156%)	-8.1% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-154%)	-10.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-167%)	-8.1% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-154%)	-7.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-149%)	-8.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-158%)	-8.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-157%)	-1.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-107%)	-8.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-157%)	-4.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-128%)	-7.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-152%)	-9.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-160%)	-5.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-133%)	-6.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-141%)	16.5% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+10%)	13.3% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-11%)	13.4% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-11%)	41.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+179%)	—	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Net Debt (USD)	$-90.77M	$-60.18M	$-123.58M	$-98.80M	$-120.33M	$-105.60M	$-100.30M	$-133.42M	$-125.65M	$-145.65M	$-286.21M	$-224.37M	$-109.43M	$-123.55M	$-116.31M	$-205.74M	$-222.60M	$-293.83M	$-393.50M	$-564.44M	$-244.37M	$-140.41M	$-134.41M	$-245.95M	—	$-96.67M	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.01	—	$0.00	$2.90	$0.05	—	$0.23	$1.23	$2.83	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-1.10	$-7.68	$-2.13	$-2.89	$-3.60	$-14.40	$-3.40	$-3.60	$-4.80	$-17.97	$-4.00	$-5.20	$-5.40	$-0.60	$-5.60	$-3.00	$-5.60	$-3.60	$-4.00	$-29.40	$-63.80	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-1.76	—	$-1.57	$-2.34	$-3.73	—	—	—	$-3.31	—	—	—	$-3.83	—	—	—	$-4.72	—	$-3.10	$-27.34	$-61.12	—	—	—	—	—	—
Book Value per Share (USD)	$11.73	$11.68	$17.06	$20.16	$22.79	$25.97	$41.37	$44.27	$47.32	—	$55.39	$58.71	$62.80	—	$65.80	$70.26	$71.81	—	$82.42	$478.52	$-386.81	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$11.73	$11.68	$17.06	$20.16	$22.79	$25.97	$41.37	$44.27	$47.32	—	$55.39	$58.71	$62.80	—	$65.80	$70.26	$71.81	—	$82.42	$478.52	$-386.81	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	21.88M	—	18.27M	14.79M	14.75M	—	12.82M	12.77M	12.71M	—	12.57M	12.51M	12.48M	—	12.42M	12.32M	12.21M	—	11.97M	2.14M	863,600	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$230.36M	$211.53M	$296.32M	$245.31M	$267.89M	$325.81M	$416.53M	$468.94M	$501.81M	—	$551.79M	$572.02M	$593.60M	—	$608.53M	$616.49M	$584.65M	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$273.67M	$248.20M	$329.12M	$298.92M	$336.52M	$382.82M	$530.70M	$566.50M	$603.16M	$654.95M	$697.57M	$736.86M	$783.83M	$833.25M	$820.03M	$868.04M	$881.25M	$929.79M	$986.47M	$1.02B	$-334.05M	$-292.53M	$-266.64M	$-240.11M	$-150.83M	$-111.11M	$850.00K

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$2.00K	$6.00K	$15.00K	$8.00K	$7.00K	$11.00K	$34.00K	$13.00K	$3.00K	$13.00K	$25.00K	$27.00K	$65.00K	$48.39M	$3.00K	$35.74M	$553.00K	$2.82M	$2.75M	$2.63M	$2.44M	$2.31M	$1.07M	$3.12M	—	—	—
Depreciation Expense (USD)	$2.33M	$2.40M	$2.57M	$3.13M	$3.44M	$5.03M	—	—	$5.02M	$5.06M	—	—	$5.03M	$5.04M	—	—	$4.19M	$4.57M	$4.09M	$3.01M	$1.96M	$1.45M	$1.10M	—	—	—	—
Net Income, GAAP (USD)	$-24.15M	$-140.72M	$-38.85M	$-42.68M	$-52.20M	$-191.94M	$-44.58M	$-45.81M	$-60.67M	$-52.93M	$-50.85M	$-63.89M	$-66.96M	$-8.40M	$-70.25M	$-36.32M	$-68.14M	$-83.71M	$-48.88M	$-62.59M	$-55.04M	$-38.86M	$-35.72M	$-100.66M	—	—	—
Operating Cash Flow (USD)	$-38.51M	$-32.25M	$-28.58M	$-34.46M	$-54.74M	$-47.24M	—	—	$-42.02M	$-40.63M	—	—	$-46.21M	$-40.27M	—	—	$-47.85M	$-33.21M	$-25.49M	$-33.95M	$-33.60M	$-26.73M	$-21.63M	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 27 quarters

Lyell Immunopharma, Inc.

Analytical Summary

27-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare LYEL with peers